Gurshan Rakhra
Gastroenterology · Newport News, VANPI 1528093143
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 215 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,548 and has fallen 96.8% since, to $49 in 2024. That places this record below the midpoint for gastroenterology clinicians in VA, where the typical reported total is $3,407.
Across 215 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$757
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$548
- Takeda Pharmaceuticals U.S.A., Inc.$506
- Johnson & Johnson$288
- Gilead$149
- Boston Scientific$148
- plus $1K from 22 others
What the payments were for
- Consulting fees$552%
- Food & beverage$3,40398%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 75 | $757 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 30 | $548 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $506 |
| Johnson & Johnson | 12 | $288 |
| Gilead | 9 | $149 |
| Boston Scientific | 3 | $148 |
| Ironwood Pharmaceuticals, Inc | 8 | $134 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Romark Laboratories, LC | 4 | $89 |
| Daiichi Sankyo Inc. | 4 | $89 |
| Merck | 5 | $88 |
| Intercept Pharmaceuticals, Inc. | 5 | $88 |
| Pfizer | 3 | $65 |
| Sanofi | 2 | $50 |
| Medtronic(2 entities) | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Ferring Pharmaceuticals Inc. | 2 | $45 |
| Concordia Pharmaceuticals Inc. | 2 | $41 |
| Alfasigma USA, Inc. | 2 | $29 |
| Nestle Healthcare Nutrition Inc. | 2 | $29 |
| Dova Pharmaceuticals | 1 | $20 |
| UCB, Inc. | 1 | $20 |
| Intra-sana Laboratories | 1 | $19 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
| Olympus America Inc. | 1 | $15 |
| Fresenius Kabi USA, LLC | 1 | $14 |
| Bristol Myers Squibb | 1 | $13 |
| Braintree Laboratories, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELARA$124
How this compares
$3,488 in reported general payments places this provider in the 50th percentile of 473 gastroenterology providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 18 | $11,186 |
| Omeprazole | 54 | $724 |
| Pantoprazole Sodium | 38 | $705 |
| Famotidine | 36 | $416 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $757 | $11,18618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 473 gastroenterology providers in Virginia.
Other gastroenterology in Newport News
- Mitchell ShiffmanNewport News$635K
- Larry ClarkLynchburg$1.2M
- Arun SanyalRichmond$855K
- Bryan SauerCharlottesville$540K
- Michael RyanNorfolk$335K
- Brian WentworthCharlottesville$276K
- Vanessa ShamiCharlottesville$210K
- Ali SiddiquiFairfax$167K
- Michael FuchsRichmond$126K
- Michael ManetasRichmond$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.